Trial NCT05033847
Publication Al Kaabi N, medRxiv, 2022
Primary outcome on the report: At 14 and 28 days post-boosting immunization, evaluate the geometric mean titers (GMTs) of IgG and neutralizing antibodies as well as the corresponding seroconversion rate (≥4-fold rise in antibody titers)

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.